
Adagene ADAG
€ 2.31
-5.5%
Geschäftsbericht 2024
hinzugefügt 31.01.2026
Adagene Finanzkreislauf 2011-2026 | ADAG
Finanzkreislauf Jährlich Adagene
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 53.8 | 125 | 182 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 182 | 53.8 | 120 |
Finanzkreislauf anderer Aktien in der Pharmaeinzelhändler
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
117 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Albireo Pharma
ALBO
|
-1.55 K | - | -0.23 % | $ 916 M | ||
|
I-Mab
IMAB
|
-1.97 K | - | - | $ 866 M | ||
|
ANI Pharmaceuticals
ANIP
|
235 | $ 81.6 | -0.49 % | $ 1.58 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Amgen
AMGN
|
261 | $ 342.65 | -0.08 % | $ 184 B | ||
|
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
Aytu BioScience
AYTU
|
174 | $ 2.63 | 1.74 % | $ 16.5 M | ||
|
Biogen
BIIB
|
387 | $ 178.24 | 1.2 % | $ 26 B | ||
|
Brickell Biotech
BBI
|
149 | - | -5.38 % | $ 6.06 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Arrowhead Pharmaceuticals
ARWR
|
8.75 | $ 70.74 | 2.34 % | $ 9.46 B | ||
|
CASI Pharmaceuticals
CASI
|
11.9 | $ 0.99 | -0.01 % | $ 135 M | ||
|
Aeterna Zentaris
AEZS
|
-34.3 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-8.96 K | - | -10.17 % | $ 12.2 K | ||
|
Catalyst Biosciences
CBIO
|
391 | $ 9.63 | -5.08 % | $ 634 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
6.09 | - | -9.72 % | $ 5.89 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
25 | - | -15.15 % | $ 60.3 M | ||
|
Berkeley Lights
BLI
|
214 | - | -7.31 % | $ 87 M | ||
|
Amneal Pharmaceuticals
AMRX
|
123 | $ 13.65 | -3.3 % | $ 4.22 B | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Cerus Corporation
CERS
|
59.2 | $ 2.32 | -0.22 % | $ 428 M | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B |